Osteoporosis beliefs and antiresorptive medication use

Maturitas

Volumn 50, Issue 3, 2005, Pages 196-208

  Cline, Richard R ^a   Farley, Joel F ^a   Hansen, Richard A ^b   Schommer, Jon C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiresorptive drugs; Health belief model; Hormone therapy; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; ATTITUDE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OSTEOPOROSIS; PRESCRIPTION; RISK ASSESSMENT; UNITED STATES;

EID: 13944284555     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.05.004     Document Type: Article

References (32)

1. Fast Facts About Osteoporosis. National Institutes of Health Osteoporosis and Related Bone Diseases National Resource Center., http://www.osteo.org/ osteofact.html; 2003 [accessed 9 September]
2. Jordan K.M., Cooper C. Epidemiology of osteoporosis. Best Prac Res Clin Rheum. 16:2002;795-806
3. Siris E.S., Miller P.D., Barrett-Connor E., et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. JAMA. 286:2001;2815-2822
4. Marottoli R.A., Berkman L.F., Cooney L.M. Decline in physical function following hip fracture. J Am Geriatr Soc. 40:1992;861-866
5. Greendale G.A., Barrett-Connor E., Ingles S., Haile R. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study. J Am Geriatr Soc. 43:1995;955-961
6. Ray N.F., Chan J.K., Thamer M., Melton L.J. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 12:1997;24-35
7. NIH Consensus Panel. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285: 785-95.
8. Management of postmenopausal osteoporosis: position statement of The North American Menopause Society. Menopause. 2002; 9: 84-101.
9. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-33.
10. Cauley J.A., Robbins J., Chen Z., et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative Randomized trial. JAMA. 290:2003;1729-1738
11. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 349:2003;523-534
12. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 2004; 291: 1701-12.
13. Brown J.P., Josse R.G. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 167:2002;S1-S34
14. Cauley J.A., Cummings S.R., Black D.M., Mascioli S.R., Seeley D.G. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 163:1990;1438-1444
15. Handa V.L., Landerman R., Hanlon J.T., et al. Do older women use estrogen replacement? Data from the Duke established populations for epidemiologic studies of the elderly (EPESE). J Am Geriatr Soc. 44:1996;1-6
16. Amonkar M.M., Mody R. Developing profiles of postmenopausal women being prescribed estrogen therapy to prevent osteoporosis. J Comm Health. 27:2002;335-350
17. Ettinger B., Chidambaran P., Pressman A. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. Am J Man Care. 7:2001;597-605
18. Lee E., Zuckerman I.H., Weiss S.R. Patterns of pharmacotherapy and counseling for osteoporosis management in visits to US ambulatory care physicians by women. Arch Intern Med. 162:2002;2362-2366
19. Cline R.R., Mott D.A. Use of antiresorptive drugs among older women: a case study in Wisconsin. Am J Health-Syst Pharm. 60:2003;453-463
20. Wallace L.S. Osteoporosis prevention in college women: application of the expanded health belief model. Am J Health Behavior. 26:2002;163-172
21. Blalock S.J., DeVellis R.F., Giorgino K.B., et al. Osteoporosis prevention in premenopausal women: using a stage model approach to examine the predictors of behavior. Health Psychol. 15:1996;84-93
22. Janz N.K., Becker M.H. The health belief model: a decade later. Health Educ Mono. 11:1984;1-47
23. Strecher VJ, Champion VL, Rosenstock IM. The health belief model and health behavior. In: Gochman DS, editor. Handbook of health behavior research I: personal and social determinants. New York: Plenum Press; 1997 p. 71-91.
24. Jones T., Fowler M.C., Hubbard D. Refining a tool to measure cues to action in encouraging health-promoting behavior - the CHAQ. Am J Health Prom. 14:2000;170-173
25. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press; 1995.
26. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw Hill; 1994.
27. Dillman, DA. Mail and Internet Surveys: the Tailored Design Method. 2nd ed. New York: John Wiley & Sons; 2000.
28. Kim K.K., Horan M.L., Gendler P., Patel M.K. Development and evaluation of the osteoporosis health belief scale. Res Nurs Health. 14:1991;155-163
29. Hosmer DS, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons; 2000.
30. Hsieh C., Novielli K.D., Diamond J.J., Cheruva D. Health beliefs and attitudes toward the prevention of osteoporosis in older women. Menopause. 8:2001;372-376
31. Cook B., Noteloviz M., Rector C., Krischer J.P. An osteoporosis patient education and screening program: results and implications. Pat Educ Coun. 17:1991;135-145
32. Jamal S.A., Ridout R., Chase C., Fielding L., Rubin L.A., Hawker G.A. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res. 14:1999;2143-2149